{"title":"Recovery of pituitary function in patients with apoplexy immediately after surgical resection of necrotic tumors.","authors":"R Kortbawi, A Ray, W R Selman, B M Arafah","doi":"10.1007/s12020-025-04222-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pituitary tumor apoplexy [PTA] and Rathke's Cleft Cyst apoplexy (RCCA) are uncommon disorders causing hypopituitarism.</p><p><strong>Objective: </strong>Examine the value of perioperative hormonal alterations in predicting recovery of impaired function in patients with PTA and RCCA.</p><p><strong>Methods: </strong>Consecutive PTA (N = 97) and RCCA (N = 41) patients who had emergent surgery received dexamethasone until surgery. Perioperative HPA function and prolactin levels were frequently assessed while hydrocortisone therapy was provided to those exhibiting clinical or biochemical evidence [cortisol <10 ug/dL; <276 nmol/L] for insufficiency. Patients with multiple perioperative cortisol levels ≥15 ug/dL [414 nmol/L] were considered to have normal postoperative HPA function.</p><p><strong>Results: </strong>Patients with PTA were more likely to be males, older, have more severe hormonal deficits and worse visual impairment than those with RCCA. Impaired HPA function and lower prolactin levels were more prevalent in patients with PTA than in those with RCCA. Perioperative recovery of HPA function was demonstrated by a brisk increase in ACTH followed by a rise in two ACTH-dependent adrenal steroids: cortisol and DHEA-S in 23/59 [39%] patients with PTA and in 16/20 [80%] others with RCCA. The perioperative rise in ACTH was mirrored by a decline in prolactin levels. Patients recovering function had higher [P < 0.01] preoperative prolactin levels than those with persistent deficit. Follow up HPA testing confirmed perioperative assessment.</p><p><strong>Conclusions: </strong>Perioperative measurements of ACTH and its dependent adrenal steroid levels accurately predict recovery of HPA function and support previously postulated role of increased intrasellar pressure and stalk compression in the pathogenesis of hypopituitarism in this setting.</p>","PeriodicalId":49211,"journal":{"name":"Endocrine","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-025-04222-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Pituitary tumor apoplexy [PTA] and Rathke's Cleft Cyst apoplexy (RCCA) are uncommon disorders causing hypopituitarism.
Objective: Examine the value of perioperative hormonal alterations in predicting recovery of impaired function in patients with PTA and RCCA.
Methods: Consecutive PTA (N = 97) and RCCA (N = 41) patients who had emergent surgery received dexamethasone until surgery. Perioperative HPA function and prolactin levels were frequently assessed while hydrocortisone therapy was provided to those exhibiting clinical or biochemical evidence [cortisol <10 ug/dL; <276 nmol/L] for insufficiency. Patients with multiple perioperative cortisol levels ≥15 ug/dL [414 nmol/L] were considered to have normal postoperative HPA function.
Results: Patients with PTA were more likely to be males, older, have more severe hormonal deficits and worse visual impairment than those with RCCA. Impaired HPA function and lower prolactin levels were more prevalent in patients with PTA than in those with RCCA. Perioperative recovery of HPA function was demonstrated by a brisk increase in ACTH followed by a rise in two ACTH-dependent adrenal steroids: cortisol and DHEA-S in 23/59 [39%] patients with PTA and in 16/20 [80%] others with RCCA. The perioperative rise in ACTH was mirrored by a decline in prolactin levels. Patients recovering function had higher [P < 0.01] preoperative prolactin levels than those with persistent deficit. Follow up HPA testing confirmed perioperative assessment.
Conclusions: Perioperative measurements of ACTH and its dependent adrenal steroid levels accurately predict recovery of HPA function and support previously postulated role of increased intrasellar pressure and stalk compression in the pathogenesis of hypopituitarism in this setting.
期刊介绍:
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.
Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.
Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.